Clinical
Trials Drive Progress
Only 3 to 6 percent of eligible
patients participate in immunotherapy clinical trials. Let’s review some of
the top considerations for patients who are exploring their clinical trial
options. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment